Gupta Sanjay, Hicks Marshall E, Wallace Michael J, Ahrar Kamran, Madoff David C, Murthy Ravi
Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Cardiovasc Intervent Radiol. 2008 Mar-Apr;31(2):342-8. doi: 10.1007/s00270-007-9250-z. Epub 2007 Dec 12.
The aim of this study was to evaluate the efficacy of outpatient management of postbiopsy pneumothoraces with small-caliber chest tubes and to assess the factors that influence the need for prolonged drainage or additional interventions. We evaluated the medical records of patients who were treated with small-caliber chest tubes attached to Heimlich valves for pneumothoraces resulting from image-guided transthoracic needle biopsy to determine the hospital admission rates, the number of days the catheters were left in place, and the need for further interventions. We also evaluated the patient, lesion, and biopsy technique characteristics to determine their influence on the need for prolonged catheter drainage or additional interventions. Of the 191 patients included in our study, 178 (93.2%) were treated as outpatients. Ten patients (5.2%) were admitted for chest tube-related problems, either for underwater suction (n = 8) or for pain control (n = 2). No further interventions were required in 146 patients (76.4%), with successful removal of the chest tubes the day after the biopsy procedure. Prolonged catheter drainage (mean, 4.3 days) was required in 44 patients (23%). Nineteen patients (9.9%) underwent additional interventions for management of pneumothorax. Presence of emphysema was noted more frequently in patients who required additional interventions or prolonged chest tube drainage than in those who did not (51.1% vs. 24.7%; p = 0.001). We conclude that use of the Heimlich valve allows safe and successful outpatient treatment of most patients requiring chest tube placement for postbiopsy pneumothorax. Additional interventions or prolonged chest tube drainage are needed more frequently in patients with emphysema in the needle path.
本研究的目的是评估采用小口径胸管对活检后气胸进行门诊处理的疗效,并评估影响延长引流或额外干预需求的因素。我们评估了因影像引导下经胸针吸活检导致气胸而接受连接海姆利希单向阀的小口径胸管治疗的患者的病历,以确定住院率、导管留置天数以及进一步干预的需求。我们还评估了患者、病变及活检技术特征,以确定它们对延长导管引流或额外干预需求的影响。在我们纳入研究的191例患者中,178例(93.2%)作为门诊患者接受治疗。10例患者(5.2%)因胸管相关问题入院,其中8例是因为需要水下吸引,2例是为了控制疼痛。146例患者(76.4%)无需进一步干预,在活检术后次日成功拔除胸管。44例患者(23%)需要延长导管引流(平均4.3天)。19例患者(9.9%)因气胸处理接受了额外干预。与无需额外干预或延长胸管引流的患者相比,需要额外干预或延长胸管引流的患者中肺气肿的发生率更高(51.1%对24.7%;p = 0.001)。我们得出结论,使用海姆利希单向阀可对大多数因活检后气胸而需要放置胸管的患者进行安全、成功的门诊治疗。穿刺路径上有肺气肿的患者更常需要额外干预或延长胸管引流。